Profile
HCWB VRTX REGN ALNY SGEN ARGX
Company Name HCW Biologics Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $9.57M $117.98B $57.12B $43.28B $43.15B $33.34B
Employees 0.04K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Hing C. Wong Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
HCWB VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 2 4 1 3 2
Quant Rating Sell Sell Buy Strong Sell Neutral Sell
Trading
HCWB VRTX REGN ALNY SGEN ARGX
Last Close $4.12 $466.36 $547.75 $317.5 $228.74 $538.64
High 52 $10.05 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $0.21 $396.64 $482.92 $224.58 $228.74 $457.68
Price vs. 52 Week High -59 % -9.75 % -54.42 % -4.34 % 0 % -19.82 %
Price vs. 52 Week Low 1861.9 % 17.58 % 13.42 % 41.38 % 0 % 17.69 %
Total Return
HCWB VRTX REGN ALNY SGEN ARGX
1 Month Return -26.16 % 4.53 % 5.78 % 4.44 % 0 % -7.71 %
3 Month Return 1623.85 % -3.3 % -4.93 % 30.53 % 0 % -4.47 %
6 Month Return 930 % 13.16 % -25.33 % 31.99 % 0 % -17.04 %
9 Month Return 649.09 % -0.34 % -45.88 % 17.2 % 0 % 3.48 %
YTD Return 823.56 % 15.81 % -23.1 % 34.93 % 0 % -12.42 %
1 Year Return 564.52 % -4.04 % -48.03 % 24.64 % 0 % 17.69 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
HCWB VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.33 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -107.18 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
HCWB VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 23.92 % 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -94.17 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM 313.31 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM 2795.87 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 103.34 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM -1657.4 % -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -226.77 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM 16.52 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM 0.06 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM 6.35 % 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM 5.5 % 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -0.32 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -0.32 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 2.48 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -978.27 % -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.93 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -226.77 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.67 -93.78 18.91 -574.08 -81.26 -431.71
Price To Operating Cash Flows Ratio TTM -12.53 -120.39 14.52 -954.11 -93.1 -512.95
Price Cash Flow Ratio TTM -12.53 -120.39 14.52 -954.11 -93.1 -512.95
Income Statement (TTM)
HCWB VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 37.38% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.03B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.03B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -0.77 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
HCWB VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.01B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.04B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $-0.01B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.01B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.03B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
HCWB VRTX REGN ALNY SGEN ARGX
Net Income $-0.03B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 41.49
AARD Aardvark Therapeutics, Inc. Common Stock 12.74
ABCL AbCellera Biologics Inc. 4.225
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.83
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.245
ABPWW 0.02
ABSI Absci Corporation 2.83
ABUS Arbutus Biopharma Corporation 3.325
ABVC ABVC BioPharma, Inc. 4.685
ABVX Abivax SA American Depositary Shares 8.26
ACAD ACADIA Pharmaceuticals Inc. 21.545
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7114
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.365
ACIU AC Immune SA 2.07
ETFs With Exposure to HCWB
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 307.49
VXF Vanguard Extended Market Index Fund 0.00004 197.68
IWC iShares Micro-Cap ETF 0.00048 133.68
VTSAX Vanguard Total Stock Market Index Fund 0 148.74
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00004 148.65
VITSX Vanguard Total Stock Market Index Fund 0 148.76
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00004 148.66
VEMPX Vanguard Extended Market Index InstlPlus 0.00004 366.84
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 279.05
Unlock